| Agripina D Grino, MD | |
|
609 James Trimble Blvd, Paintsville, KY 41240-1055 | |
| (606) 789-6844 | |
| (606) 789-4157 |
| Full Name | Agripina D Grino |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 609 James Trimble Blvd, Paintsville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720039340 | NPI | - | NPPES |
| 64197163 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 19716 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Agripina D Grino, MD 609 James Trimble Blvd, Paintsville, KY 41240-1055 Ph: (606) 789-6844 | Agripina D Grino, MD 609 James Trimble Blvd, Paintsville, KY 41240-1055 Ph: (606) 789-6844 |
News Archive
The study was a cooperative effort between the team headed by assistant professor Dr Jürgen Knobloch from the Medical Clinic III for Pneumology, Sleep and Respiratory Medicine at the Bergmannsheil University Hospital in Bochum, Germany, and Prof Dr Andrea Koch, member of the German Center for Lung Research, previously in Bochum, now at the Medical Clinic V for Pneumology at the LMU University Hospital in Munich, as well as a team from the company RespiVert Ltd, a subsidiary of Janssen Biotech Inc., and Prof Dr Erich Stoelben from the Lung Clinic in Köln-Merheim.
Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.
Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT), a common pre-diabetic condition.
China Medical Technologies, Inc. (the "Company"), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will attend the 62nd China International Medical Equipment Fair ("CMEF") from October 28 to October 31, 2009 in Chengdu, China.
Researchers from Charité - Universitätsmedizin Berlin have analyzed the underlying electrophysiological indicators of subarachnoid hemorrhage, the second most common type of brain hemorrhage that can lead to ischemic stroke within a matter of days.
› Verified 1 days ago
Narong Chalothorn, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 609 James Trimble Blvd, Paintsville, KY 41240 Phone: 606-789-6844 Fax: 606-789-4157 |